HomeInsightsStock Comparison

Beta Drugs Ltd vs J B Chemicals Pharmaceuticals Ltd Stock Comparison

Beta Drugs Ltd vs J B Chemicals Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Beta Drugs Ltd is ₹ 1673 as of 16 Jul 15:09.
  • The P/E Ratio of Beta Drugs Ltd changed from 4.1 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of J B Chemicals & Pharmaceuticals Ltd changed from 14.4 on March 2020 to 38.3 on March 2025 . This represents a CAGR of 17.71% over 6 years.
  • The Market Cap of Beta Drugs Ltd changed from ₹ 38.46 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 3928 crore on March 2020 to ₹ 25253 crore on March 2025 . This represents a CAGR of 36.36% over 6 years.
  • The revenue of Beta Drugs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of J B Chemicals & Pharmaceuticals Ltd for the Mar '25 is ₹ 963.96 crore as compare to the Dec '24 revenue of ₹ 971.49 crore. This represent the decline of -0.78%.
  • The ebitda of Beta Drugs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of J B Chemicals & Pharmaceuticals Ltd for the Mar '25 is ₹ 240.92 crore as compare to the Dec '24 ebitda of ₹ 262.51 crore. This represent the decline of -8.22%.
  • The net profit of Beta Drugs Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of J B Chemicals & Pharmaceuticals Ltd changed from ₹ 142.32 crore to ₹ 145.69 crore over 8 quarters. This represents a CAGR of 1.18% .
  • The Dividend Payout of Beta Drugs Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of J B Chemicals & Pharmaceuticals Ltd changed from 31.71 % on March 2020 to 36.98 % on March 2025 . This represents a CAGR of 2.60% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Beta Drugs Ltd

  • Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
  • Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
  • Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
  • The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
  • The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

About J B Chemicals & Pharmaceuticals Ltd

  • J B Chemicals & Pharmaceuticals Limited (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals on December 18, 1976.
  • The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and Active Pharmaceutical Ingredients (APIs).
  • The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
  • The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
  • Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.

Beta Drugs Ltd News Hub

News

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 15 May 2025. Po...

Read more

10 May 2025 10:59

News

Beta Drugs announces board meeting date

Beta Drugs will hold a meeting of the Board of Directors of the Company on 27 March 2025. ...

Read more

20 Mar 2025 14:34

News

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 5 February 2025...

Read more

03 Feb 2025 10:49

News

Beta Drugs schedules EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

28 Nov 2024 15:41

News

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 6 November 2024...

Read more

04 Nov 2024 14:01

News

Beta Drugs to conduct EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

21 Oct 2024 13:59

J B Chemicals & Pharmaceuticals Ltd News Hub

News

J B Chemicals & Pharmaceuticals to conduct AGM

J B Chemicals & Pharmaceuticals announced that the Annual General Meeting(AGM) of the comp...

Read more

12 Jul 2025 09:53

News

J B Chemicals & Pharmaceuticals Ltd leads losers in 'A' group

Jyoti CNC Automation Ltd, Karnataka Bank Ltd, Narayana Hrudayalaya Ltd and Home First Fina...

Read more

30 Jun 2025 15:00

News

J B Chemicals & Pharmaceuticals receives USFDA approval for Amitriptyline Hydrochloride Tablets

J B Chemicals & Pharmaceuticals has received approval from United States Food and Drug Adm...

Read more

26 Jun 2025 18:33

News

JB Chemicals receives USFDA approval for Amitriptyline Hydrochloride tablets

The approved dosages'10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg'are indicated for the ...

Read more

25 Jun 2025 12:22

News

J B Chemicals receives USFDA approval for Amitriptyline Hydrochloride Tablets

J B Chemicals & Pharmaceuticals has received approval from United States Food and Drug Adm...

Read more

24 Jun 2025 18:31

News

J B Chemicals & Pharmaceuticals allots 85,390 equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 85,390 equity shares under ESOS. Consequently...

Read more

11 Jun 2025 18:10

SWOT Analysis Of Beta Drugs Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of J B Chemicals & Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Beta Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for J B Chemicals & Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Beta Drugs Ltd and J B Chemicals & Pharmaceuticals Ltd

Which company has a larger market capitalization, Beta Drugs Ltd or J B Chemicals & Pharmaceuticals Ltd?

Market cap of Beta Drugs Ltd is 1,746 Cr while Market cap of J B Chemicals & Pharmaceuticals Ltd is 25,772 Cr

What are the key factors driving the stock performance of Beta Drugs Ltd and J B Chemicals & Pharmaceuticals Ltd?

The stock performance of Beta Drugs Ltd and J B Chemicals & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beta Drugs Ltd and J B Chemicals & Pharmaceuticals Ltd?

As of July 16, 2025, the Beta Drugs Ltd stock price is INR ₹1730.0. On the other hand, J B Chemicals & Pharmaceuticals Ltd stock price is INR ₹1651.45.

How do dividend payouts of Beta Drugs Ltd and J B Chemicals & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Beta Drugs Ltd and J B Chemicals & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions